Alphatec Holdings Inc

ATEC is in an early Stage 1 consolidation following a terminal decline, with price stabilizing above repaired short-term EMAs and reclaiming the 50 DMA. Accumulation signatures include a breakout on expanding volume and rising RSI without divergence. The medium-term bias is bullish based on repaired structure, but near-term resistance and slight overbought context warrant patience. Execution is deferred, stalking for a pullback into the EMA support zone before engagement.

• ↑Total revenue $192M, up 14% YoY; surgical revenue $178M, up 17% YoY.
• ↑Procedural volume rose 21%; new surgeon adoption increased 23%.
• ↓EOS segment revenue dropped to $14M from $17M, underperforming goals.